These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29203593)

  • 1. Loss of p53 compensates osteopenia in murine Mysm1 deficiency.
    Haffner-Luntzer M; Kovtun A; Fischer V; Prystaz K; Hainzl A; Kroeger CM; Krikki I; Brinker TJ; Ignatius A; Gatzka M
    FASEB J; 2018 Apr; 32(4):1957-1968. PubMed ID: 29203593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of H2A deubiquitinase 2A-DUB/Mysm1 and the p19(ARF)/p53 axis in hematopoiesis, early T-cell development and tissue differentiation.
    Gatzka M; Tasdogan A; Hainzl A; Allies G; Maity P; Wilms C; Wlaschek M; Scharffetter-Kochanek K
    Cell Death Differ; 2015 Sep; 22(9):1451-62. PubMed ID: 25613381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2A-DUB/Mysm1 Regulates Epidermal Development in Part by Suppressing p53-Mediated Programs.
    Wilms C; Krikki I; Hainzl A; Kilo S; Alupei M; Makrantonaki E; Wagner M; Kroeger CM; Brinker TJ; Gatzka M
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitinase MYSM1 Is Essential for Normal Bone Formation and Mesenchymal Stem Cell Differentiation.
    Li P; Yang YM; Sanchez S; Cui DC; Dang RJ; Wang XY; Lin QX; Wang Y; Wang C; Chen DF; Chen SY; Jiang XX; Wen N
    Sci Rep; 2016 Feb; 6():22211. PubMed ID: 26915790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance.
    Belle JI; Petrov JC; Langlais D; Robert F; Cencic R; Shen S; Pelletier J; Gros P; Nijnik A
    Cell Death Differ; 2016 May; 23(5):759-75. PubMed ID: 26768662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8
    Förster M; Boora RK; Petrov JC; Fodil N; Albanese I; Kim J; Gros P; Nijnik A
    Immunology; 2017 May; 151(1):110-121. PubMed ID: 28066899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 deficiency promotes bone regeneration by functional regulation of mesenchymal stromal cells and osteoblasts.
    Nagashima T; Ninomiya T; Nakamura Y; Nishimura S; Ohashi A; Aoki J; Mizoguchi T; Tonogi M; Takahashi T
    J Bone Miner Metab; 2022 May; 40(3):434-447. PubMed ID: 35195777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mediates loss of hematopoietic stem cell function and lymphopenia in Mysm1 deficiency.
    Belle JI; Langlais D; Petrov JC; Pardo M; Jones RG; Gros P; Nijnik A
    Blood; 2015 Apr; 125(15):2344-8. PubMed ID: 25710881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation.
    Nijnik A; Clare S; Hale C; Raisen C; McIntyre RE; Yusa K; Everitt AR; Mottram L; Podrini C; Lucas M; Estabel J; Goulding D; ; ; Adams N; Ramirez-Solis R; White JK; Adams DJ; Hancock RE; Dougan G
    Blood; 2012 Feb; 119(6):1370-9. PubMed ID: 22184403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth.
    Wilms C; Kroeger CM; Hainzl AV; Banik I; Bruno C; Krikki I; Farsam V; Wlaschek M; Gatzka MV
    Oncotarget; 2017 Sep; 8(40):67287-67299. PubMed ID: 28978033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
    Sanvoranart T; Supokawej A; Kheolamai P; U-Pratya Y; Klincumhom N; Manochantr S; Wattanapanitch M; Issaragrisil S
    Biochem Biophys Res Commun; 2014 May; 447(4):580-5. PubMed ID: 24747566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix remodeling associated 7 promotes differentiation of bone marrow mesenchymal stem cells toward osteoblasts.
    Zhou Z; Shen Y; Yin J; Xi F; Xu R; Lin D; Saijilafu ; Chen J; Wang Y
    J Cell Physiol; 2019 Aug; 234(10):18053-18064. PubMed ID: 30843215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitinase MYSM1 Is Essential for Normal Fetal Liver Hematopoiesis and for the Maintenance of Hematopoietic Stem Cells in Adult Bone Marrow.
    Förster M; Belle JI; Petrov JC; Ryder EJ; Clare S; Nijnik A
    Stem Cells Dev; 2015 Aug; 24(16):1865-77. PubMed ID: 26125289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Signatures at the RUNX2-P1 and Sp7 Gene Promoters Control Osteogenic Lineage Commitment of Umbilical Cord-Derived Mesenchymal Stem Cells.
    Sepulveda H; Aguilar R; Prieto CP; Bustos F; Aedo S; Lattus J; van Zundert B; Palma V; Montecino M
    J Cell Physiol; 2017 Sep; 232(9):2519-2527. PubMed ID: 27689934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mysm1 expression in the bone marrow niche is not essential for hematopoietic maintenance.
    Petrov JC; Nijnik A
    Exp Hematol; 2017 Mar; 47():76-82.e3. PubMed ID: 27833034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation.
    Wang T; Nandakumar V; Jiang XX; Jones L; Yang AG; Huang XF; Chen SY
    Blood; 2013 Oct; 122(16):2812-22. PubMed ID: 24014243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kif3a deficiency reverses the skeletal abnormalities in Pkd1 deficient mice by restoring the balance between osteogenesis and adipogenesis.
    Qiu N; Cao L; David V; Quarles LD; Xiao Z
    PLoS One; 2010 Dec; 5(12):e15240. PubMed ID: 21151991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
    Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
    J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibin α-subunit inhibits BMP9-induced osteogenic differentiation through blocking BMP/Smad signal and activating NF-κB signal in mesenchymal stem cells.
    Huang M; Cheng YL; Zeng JT; Su XY; Liu H
    J Cell Biochem; 2018 Nov; 119(10):8271-8281. PubMed ID: 29923343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pax2 is essential for proliferation and osteogenic differentiation of mouse mesenchymal stem cells via Runx2.
    Lu M; Guo S; Hong F; Zhang Y; Yuan L; Ma C; Ma J
    Exp Cell Res; 2018 Oct; 371(2):342-352. PubMed ID: 30144446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.